Resch, B; Gusenleitner, W; Müller, WD; Haas, J.
Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29-32 weeks.
EUR J CLIN MICROBIOL INFECT D. 2006; 25(2): 120-122.
Doi: 10.1007/s10096-005-0082-y
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar